Schistosomes acquire amino acids for growth, development, and reproduc
tion by catabolizing hemoglobin obtained from ingested host erythrocyt
es. While the biochemical pathway(s) involved has not been determined
definitively, a number of proteases including schistosome legumain and
cathepsin L-, D-, B- and C-like enzymes have been ascribed roles in t
he degradation of hemoglobin to diffusible peptides. Transcripts encod
ing these schistosome proteases, which appear to be expressed in the g
astrodermis and cecum of the schistosome, have been reported. Because
these enzymes are candidate targets at which to direct novel anti-schi
stosomal therapies, the comparative biochemistry of these and their co
unterpart mammalian proteases is now the focus of research in a number
of laboratories. This paper reviews reports dating from 40 years ago
to the present on how schistosomes digest host-derived hemoglobin, and
interprets apparent anomalies in some earlier compared to later repor
ts, the latter having benefited from the availability of PCR and gene
cloning technologies. More specifically, the review concentrates on fi
ve proteolytic enzymes, and their associated genes, which have been as
cribed key roles in the pathway of hemoglobin degradation. (C) 1997 El
sevier Science B.V.